CAS 1609392-27-9 | BMS-986165

Introduction and application of CAS 1609392-27-9 | BMS-986165

BMS-986165 is a P-glycoprotein (P-gp) inhibitor that has been shown to reduce the absorption of ciclosporin, tacrolimus, and everolimus in vitro. BMS-986165 has an activity index of 100% and inhibits the inflammatory response by inhibiting the production of cytokines.

It has been found to be effective for treating bowel diseases, such as ulcerative colitis and Crohn's disease. The drug also may be used for the treatment of autoimmune diseases, such as psoriasis or rheumatoid arthritis. BMS-986165 is administered orally and is rapidly absorbed. It is metabolized by CYP3A4 and excreted in urine as metabolites.

Synonyms:

6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide;

Specification of CAS 1609392-27-9 | BMS-986165

Package and transportation of Introduction and application of CAS 1609392-27-9 | BMS-986165

Package:0.1g,1g,5g,25g,100g,500g,1kg

Transportation: by courier/ by air/ by sea

Related Articles of CAS 1609392-27-9 | BMS-986165

Highly selective inhibition of tyrosine kinase 2 (TYK2) for the treatment of autoimmune diseases: discovery of the allosteric inhibitor BMS-986165

ST Wrobleski, R Moslin, S Lin, Y Zhang… - Journal of medicinal …, 2019 - ACS Publications

… Herein we report the late stage optimization efforts including a structure-guided design and

water displacement strategy that led to the discovery of BMS-986165 (11) as a high affinity …

Hot Tags: cas 1609392-27-9 | bms-986165, China cas 1609392-27-9 | bms-986165 manufacturers, factory, Methyl toluenesulfonate, 4 Amino 4H 1 2 4 triazole, 3 deoxy adenosin, Cellulose Acetate Butyrate, Cordycepin, Pharmaceutical Intermediates